Pharma Focus Asia


This section presents pharmaceutical projects that are announced from time-to-time around the world.

Vetter Expands Manufacturing Sites in USA and Germany

Vetter intends to relocate and expand its development services site from Skokie to Des Plaines, Illinois, bolstering its US presence The project also includes investments in commercial operations

SGS North America Expands Biologics Testing Capabilities in USA

SGS North America has expanded its capacity and capabilities to enhance biologics testing services in the USA The 60,000 squarefoot, stateoftheart facility in Lincolnshire

Bora Pharmaceuticals Expands Sterile Manufacturing Facility in Maryland, USA

Bora Pharmaceuticals plans for the expansion of sterile manufacturing facility in Maryland, USA to provide Sterile FillFinish Services The newly acquired 87,000

Novo Nordisk Invests US$4.1 billion to Expand Production Capacity in USA

Novo Nordisk plans to invest U$41 billion towards constructing a second fill and finish manufacturing facility in the USA The expansion project will increase production capacity significantly

LFB Biomanufacturing Expands its Biomedical Production Capacity in France, Europe

LFB Biomanufacturing is planning a capacity expansion of its industrial site in France, Europe The expansion will not only boost production capabilities

Thermo Fisher Scientific Invests US$58 million to Expand Research Laboratory in Wisconsin, USA

Thermo Fisher Scientific is investing $58 million to expand its GMP lab in Wisconsin, USA This new stateoftheart facility spans 72,500 square feet and includes a clinical research laboratory building

Sanofi Invests US$3.75 million (€3.5) to Open New Bioproduction Capacity in France

Sanofi is investing US$375 million 35 million to open new bioproduction capacity at its facilities in VitrysurSeine Val dae Marne, Loe Trait SeineMaritime, and Lyon Gerland Rhne in France

Kyowa Kirin Invests US$530 million for New Biologics Manufacturing Plant in USA

Kyowa Kirin invests US$530 million to construct a stateoftheart manufacturing facility in North Carolina, USA The 171,700squarefoot, tworeactor facility will accelerate the development

Aurigene Pharmaceutical Services Opens New Biologics Facility in India

Aurigene Pharmaceutical Services is set to open a new biologics facility in India, providing process development and clinicalscale manufacturing capabilities

Kymanox Expands Laboratory Service Offerings in USA

Kymanox is planning to expand its device design and testing facility, significantly enhancing its laboratory testing capabilities and increasing its CGxP footprint in the USA

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference